Entrada Therapeutics Inc (TRDA) stock news · rev $25.4M
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
This TRDA news page leads with what Entrada Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for TRDA yet. We will not pad this page with generic market recap.
Latest reported TRDA revenue for 2025-12-31 was $25.4M. Net income was -$143.8M. Revenue was down 87.9% from 2024-12-31 to 2025-12-31. TRDA currently screens at market cap $274.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TRDA stock page; for the tape open the quote page.
TRDA stock news FAQ
What are TRDA's latest revenue and net income?
Latest cached Entrada Therapeutics Inc (TRDA) revenue for Dec 31, 2025 was $25.4M. Net income was -$143.8M. Statements: https://lician.com/financials/trda
How did TRDA revenue change from the prior cached period?
Cached Entrada Therapeutics Inc (TRDA) revenue was down 87.9% from $210.8M (Dec 31, 2024) to $25.4M (Dec 31, 2025). Statements: https://lician.com/financials/trda
What is TRDA's market cap?
Entrada Therapeutics Inc (TRDA) market cap is $274.4M on the latest cached fundamentals snapshot.
What kind of company is TRDA?
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Where is TRDA stock news listed?
Cached stock news for Entrada Therapeutics Inc (TRDA) is listed at https://lician.com/news/trda. Filings: https://lician.com/sec/trda
Not investment advice.